
Enko Chem, Inc. is an AI-informed crop health company that applies innovative drug discovery techniques from the pharmaceutical industry to agriculture. Their proprietary technology platform focuses on developing effective, earth-friendly solutions for crop production, enabling farmers to use less product while achieving better results. By leveraging artificial intelligence, machine learning, and DNA-encoded libraries, Enko aims to set new industry standards in safety, sustainability, and environmental impact, addressing the urgent challenges in global agriculture.

Enko Chem, Inc. is an AI-informed crop health company that applies innovative drug discovery techniques from the pharmaceutical industry to agriculture. Their proprietary technology platform focuses on developing effective, earth-friendly solutions for crop production, enabling farmers to use less product while achieving better results. By leveraging artificial intelligence, machine learning, and DNA-encoded libraries, Enko aims to set new industry standards in safety, sustainability, and environmental impact, addressing the urgent challenges in global agriculture.
Sector: Agriculture / AgTech (crop protection)
Founded: 2017
Headquarters: Mystic, Connecticut, United States
Founder & CEO: Jacqueline Heard
Tech focus: AI/ML, predictive analytics, DNA-encoded libraries
Last disclosed round: Series C (announced 2022-07-27; most recent listed Jan 31, 2023)
Crop protection against pests and disease; reducing product use and environmental impact in agriculture.
2017
Agriculture and Farming
Series C announced Jul 27, 2022; most recent funding activity listed Jan 31, 2023 in some records.
“Backed by strategic ag and venture investors including Nufarm, Rabobank Food & Agri Innovation Fund, Castor Ventures, Endeavor8, Finistere Ventures, Bill & Melinda Gates Foundation”